Get the Stockscreener App
1.33
3.91%
0.05
After Hours:
1.35
0.02
+1.50%
Pyxis Oncology Inc stock is traded at $1.33, with a volume of 211.17K.
It is up +3.91% in the last 24 hours and up +20.91% over the past month.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
See More
Previous Close:
$1.28
Open:
$1.28
24h Volume:
211.17K
Relative Volume:
0.41
Market Cap:
$82.48M
Revenue:
-
Net Income/Loss:
$-73.79M
P/E Ratio:
-0.7228
EPS:
-1.84
Net Cash Flow:
$-77.44M
1W Performance:
-2.92%
1M Performance:
+20.91%
6M Performance:
+11.76%
1Y Performance:
-64.91%
1-Day Range:
$1.27
$1.34
1-Week Range:
$1.27
$1.44
52-Week Range:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Name
Pyxis Oncology Inc
Sector
Industry
Phone
(617) 221-9059
Address
321 HARRISON AVENUE, BOSTON
Compare PYXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.33 | 79.38M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-21-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-08-24 | Initiated | Stephens | Overweight |
| Aug-08-24 | Initiated | Stifel | Buy |
| May-07-24 | Resumed | Jefferies | Buy |
| Feb-09-24 | Initiated | BTIG Research | Buy |
| Jan-23-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-02-21 | Initiated | BofA Securities | Neutral |
| Nov-02-21 | Initiated | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Jefferies | Buy |
View All
Pyxis Oncology Inc Stock (PYXS) Latest News
Will Pyxis Oncology Inc. benefit from macro trendsMarket Growth Report & Weekly Top Gainers Trade List - Newser
Is Pyxis Oncology Inc. still worth holding after the dipJuly 2025 News Drivers & Accurate Trade Setup Notifications - Newser
Applying big data sentiment scoring on Pyxis Oncology Inc.Weekly Market Report & Fast Moving Stock Watchlists - Newser
Is Pyxis Oncology Inc. stock entering bullish territoryPortfolio Value Summary & Stepwise Trade Execution Plans - Newser
Applying chart zones and confluence areas to Pyxis Oncology Inc.M&A Rumor & Technical Pattern Based Signals - Newser
Has Pyxis Oncology Inc. formed a bullish divergencePortfolio Update Summary & High Conviction Buy Zone Alerts - Newser
Forecasting Pyxis Oncology Inc. price range with options dataQuarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - Newser
Will Pyxis Oncology Inc. stock recover after recent drop2025 Biggest Moves & Short-Term Trading Alerts - Newser
What is the long term forecast for Pyxis Oncology Inc. stock2025 Volume Leaders & Momentum Based Trading Ideas - خودرو بانک
Is it too late to sell Pyxis Oncology Inc.Portfolio Profit Report & Safe Capital Growth Tips - Newser
Can technical indicators confirm Pyxis Oncology Inc.’s reversalMarket Growth Summary & Risk Managed Trade Strategies - Newser
How to integrate Pyxis Oncology Inc. into portfolio analysis tools2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
Using data models to predict Pyxis Oncology Inc. stock movementPortfolio Return Report & Low Drawdown Trading Techniques - Newser
What’s the recovery path for long term holders of Pyxis Oncology Inc.Insider Selling & Verified Swing Trading Watchlist - Newser
Visual analytics tools that track Pyxis Oncology Inc. performanceTrade Risk Report & Safe Entry Trade Signal Reports - Newser
Is Pyxis Oncology Inc. stock risky to hold nowPortfolio Value Report & AI Powered Market Entry Strategies - kpenews.com
Heatmap analysis for Pyxis Oncology Inc. and competitorsTrade Analysis Report & Community Consensus Trade Alerts - Newser
What MACD signals say about Pyxis Oncology Inc.2025 Growth vs Value & Consistent Income Trade Recommendations - Newser
Moving Average Crossover Confirms Uptrend in Pyxis Oncology Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Can Pyxis Oncology Inc. recover in the next quarterEarnings Performance Report & Real-Time Stock Entry Alerts - Newser
Long term hold vs stop loss in Pyxis Oncology Inc.2025 Trade Ideas & Scalable Portfolio Growth Ideas - Newser
Pyxis Oncology Inc. stock chart pattern explainedSell Signal & Growth Focused Entry Reports - Newser
Pyxis Oncology Inc. Rebound Backed by Sentiment Shift getLinesFromResByArray error: size == 0 - newsyoung.net
Is now a turning point for Pyxis Oncology Inc.Market Trend Review & Community Verified Watchlist Alerts - Newser
Published on: 2025-08-29 02:34:12 - Newser
Pyxis Oncology Inc Stock (PYXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):